HOTH News and Press, Hoth Therapeutics Inc. From 06/18/21

GreenApple78/iStock via Getty Images Hoth Therapeutics ([[HOTH]] -1.2%) has entered into an amendment to a license agreement signed with the U.S. Army Medical Research and Development Command (USAMRDC). Per the original agreement that became effective on December 22, 2020, USAMRDC granted the...

Hoth Therapeutics Announces Sponsored Research Agreement with Washington University for Novel Alzheimer's Therapeutic HT-ALZ PR Newswire NEW YORK , June 7, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical compan...

Hoth Therapeutics (HOTH) gains 4% premarket after announcing positive results from a preclinical trial, reinforcing the potential of HT-KIT, a new molecular entity under development for treatment of mast cell-derived cancers and anaphylaxis.The preclinical animal trials we...

Hoth Therapeutics Shares Positive Preclinical Results of Novel HT-KIT Therapeutic Shareholder Presentation Today to Further Highlight Results HT- KIT Reduces KIT expression and induces apoptosis of neoplastic human mast cells Inhibits tumor growth in humanized xenograft ...

Hoth Therapeutics Plans Shareholder Presentation on HT-KIT Therapeutic's Preclinical Results for Rare Cancers PR Newswire NEW YORK , June 1, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...

Hoth Therapeutics Announces Participation at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire NEW YORK , May 24, 2021 /PRNewswire/ -- Hoth Therapeutics , Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...

Hoth Therapeutics (HOTH) plans to host a virtual information session on its pipeline product, HT-005 Z-Pods on Tuesday, May 18th at 11:00am ET for interested shareholders.HT-005 Z-Pods is a novel endocannibinoid treatment for patients with Cutaneous Lupus Erythematosus ((CLE))....

Hoth Therapeutics Provides Shareholder Update on Novel Endocannabinoid Therapeutic for Cutaneous Lupus Erythematosus PR Newswire NEW YORK , May 13, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...

Hoth Therapeutics ([[HOTH]] +5.3%) has expanded its research agreement with Virginia Commonwealth University ((VCU)) for a potential COVID-19 treatment. Based on positive preclinical results, Hoth has amended its original scientific agreement with VCU and has agreed to fur...

Hoth Therapeutics and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic PR Newswire NEW YORK , May 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has expa...